Skip to content
Menu

Sensus Healthcare, Inc. SRTS

Full chart Compare
Set alert

Price alert · SRTS

All alert types
2.36 USD +0.06 (+2.61%)

Regular-session close

2.40 +0.04 +1.69%

After hours · Nov 19, 7:30 PM ET

2.30 Day range 2.51
2.14 52-week range 5.49
YTD
-40.70%
1 year
-41.58%

 

No chart data for this range yet.
Market cap
38.85M
Revenue (ttm)
36.37M
Profit margin
18.27%
EPS (ttm)
-0.97
Shares out
16.39M
Forward P/E
11.84
YTD return
-40.70%
1-year return
-41.58%
Volume
170.42K
Avg volume
206.16K
Open
2.30
Previous close
2.30
Day's range
2.30 – 2.51
52-week range
2.14 – 5.49
Beta
1.04
Price target
11.50 (+387.3%)

Key statistics

50-day average
7.53
200-day average
5.81
Enterprise value
112.66M
Price / sales
3.10
Price / book
4.39
Revenue growth
155.70%
Free cash flow
-2.92M
Total cash
14.52M
Total debt
225.00K
Return on equity
13.44%
Short % of float
3.61%

Fundamental scorecard

7 of 25 checks passed on SRTS’s reported financials

ValueGrowthProfitabilityHealthDividend

7of 25 checks passed

  • Value 2 of 5
  • Growth 2 of 5
  • Profitability 0 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
SRTS Revenue — quarterly 6.00M
SRTS Net income — quarterly -1.49M
SRTS EPS — quarterly -0.09

Earnings

SRTS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 13, 2025Dec 1, 20240.10———
Nov 14, 2024Sep 1, 2024-0.020.07+0.09+450.00%
Aug 8, 2024Jun 1, 20240.030.10+0.07+233.33%
May 9, 2024Mar 1, 2024-0.040.14+0.18+450.00%
Feb 8, 2024Dec 1, 20230.120.26+0.14+116.67%
Nov 9, 2023Sep 1, 2023-0.01-0.09-0.08-800.00%

Upgrades / downgrades

SRTS analyst upgrades and downgrades
DateFirmActionFromTo
Nov 18, 2024HC Wainwright & Co.mainBuyBuy
Nov 15, 2024Maxim GroupmainBuyBuy
Aug 12, 2024HC Wainwright & Co.reitBuyBuy
May 13, 2024HC Wainwright & Co.mainBuyBuy
May 10, 2024Maxim GroupmainBuyBuy
Nov 13, 2023HC Wainwright & Co.reitBuyBuy

About Sensus Healthcare, Inc.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on SRTS — it syncs with the Stock Master app.

Insider holders

SRTS insider holders
InsiderRelationLatest transactionDateShares held
CORNISH MEGANDirectorStock Award(Grant)Dec 16, 202432,000
HEINRICH JOHN P. PH.D.DirectorSaleMay 19, 202459,940
MCCALL WILLIAM HDirectorStock Award(Grant)Dec 16, 202430,000
O'REAR SAMUELDirectorPurchaseMay 8, 2023143,570
PETRELLI ANTHONY BENEDICTDirectorStock Award(Grant)Dec 16, 202466,466
SARDANO JOSEPH CChief Executive OfficerPurchaseSep 13, 20231,175,290

Institution ownership

SRTS institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc4.75%779,0525.35MSep 29, 2024
Renaissance Technologies, LLC2.50%409,3342.81MSep 29, 2024
Acadian Asset Management. LLC1.85%303,9152.09MSep 29, 2024
Dimensional Fund Advisors LP1.77%289,6151.99MSep 29, 2024
Morgan Stanley1.13%185,2681.27MSep 29, 2024
Two Sigma Investments, LP0.94%154,0441.06MSep 29, 2024

Fund ownership

SRTS fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund3.39%555,5623.82MSep 29, 2024
Vanguard Extended Market Index Fund1.27%207,4231.42MSep 29, 2024
Perritt Microcap Opportunities Fund0.58%95,000652.65KSep 29, 2024
Fidelity Extended Market Index Fund0.46%76,080522.67KOct 30, 2024
Unified Series Trust-Auer Growth Fd0.31%50,000343.50KOct 30, 2024
iShares Micro Cap ETF0.21%34,229235.15KOct 30, 2024